Association of sodium-glucose cotransporter-2 inhibitor use and mortality in patients with endometrial cancer: a retrospective cohort study
As one of the treatments for T2DM, SGLT2i treatment in patients with endometrial cancer was associated with significantly reduced all-cause mortality, highlighting its potential as an adjunctive therapeutic strategy.
Authors
- Mingxia Ye (ORCID: https://orcid.org/0000-0003-4741-0026)
- Yuanguang Meng (ORCID: https://orcid.org/0000-0002-4957-3999)
- M.J. Lucero (ORCID: https://orcid.org/0000-0002-9112-1304)
- Ling Zhou (ORCID: https://orcid.org/0000-0002-6947-2028)
- Heping Zhang (ORCID: https://orcid.org/0000-0003-3608-2549)
- Xiaoliang Wang (ORCID: https://orcid.org/0000-0002-2345-7308)
- Min Wang (ORCID: https://orcid.org/0000-0001-9670-6937)
- Weijun Pan (ORCID: https://orcid.org/0000-0002-9402-135X)
Institutions
- Chinese PLA General Hospital (CN)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1186/s12885-025-14453-w
- Citations
- 1
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 1.05